Immunological and virological failure after antiretroviral therapy is associated with enhanced peripheral and thymic pathogenicity

J Infect Dis. 2003 Jun 15;187(12):1915-23. doi: 10.1086/375351. Epub 2003 Jun 4.

Abstract

T cell dynamics and viral genotype were studied in human immunodeficiency virus 1-infected individuals receiving antiretroviral therapy who were viremic and had either increasing (discordant immunological responders) or decreasing (nonresponders) CD4(+) T cell counts. A comparison was made with treated individuals who were not viremic and had increasing CD4(+) T cell counts (complete responders). Nonresponders had higher CD4(+) T cell proliferation (as assessed by Ki67 expression) and immune activation (as assessed by CD38 and human leukocyte antigen-DR expression), together with a reduction in T cell receptor excision circles, compared with discordant immunological responders and complete responders, which suggests that there is enhanced viral pathogenicity in both peripheral T cells and the thymus. Although there was a high prevalence of mutations in the protease and reverse transcriptase genes in discordant immunological responders, these changes were also observed in nonresponders.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-HIV Agents / therapeutic use*
  • CD4 Lymphocyte Count
  • CD4-Positive T-Lymphocytes / cytology*
  • CD4-Positive T-Lymphocytes / immunology*
  • Cross-Sectional Studies
  • Drug Resistance, Viral / genetics
  • Female
  • Genotype
  • HIV Infections / drug therapy*
  • HIV Infections / immunology*
  • HIV Infections / virology
  • HIV-1 / genetics*
  • Humans
  • Lymphocyte Activation
  • Male
  • Middle Aged
  • Thymus Gland / immunology*
  • Viral Load
  • Viremia

Substances

  • Anti-HIV Agents